Traws Pharma, Inc. (TRAW)

Latest Insider Confidence Score

2025Q4

50.0
Bearish

Company insider confidence (by quarter)

2013Q3 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Michael & Jane Hoffman 2013 Descendants 10% Owner 4,518,275 Feb 24, 2014
Baxalta GmbH — 2,603,295 May 8, 2015
Baxalta Inc — 2,603,295 May 8, 2015
Baxter International Inc 10% Owner 2,273,295 Aug 1, 2013
Baxter Healthcare SA 10% Owner 2,273,295 Aug 1, 2013

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 12, 2025 Dec 16, 2025 Leaman John Harold Director Neutral 90.0 +4,058 100.00% ✗ -
Dec 12, 2025 Dec 16, 2025 Clarke Trafford Director Neutral 90.0 +6,157 100.00% ✗ -
Dec 12, 2025 Dec 16, 2025 CAUTREELS WERNER Director Neutral 82.5 +4,874 4.67% ✗ -
Dec 12, 2025 Dec 16, 2025 Shoemaker Mary Teresa Director Neutral 90.0 +6,157 4560.74% ✗ -
Dec 12, 2025 Dec 16, 2025 STOVER JACK E Director Neutral 90.0 +6,157 76962.50% ✗ -
Dec 12, 2025 Dec 16, 2025 Dukes Iain D. CEO Neutral 90.0 +36,943 27.53% ✗ -
Dec 12, 2025 Dec 16, 2025 Pauza Charles David Chief Science Officer Virology Neutral 90.0 +18,471 18.94% ✗ -
Dec 12, 2025 Dec 16, 2025 Redfield Robert Chief Medical Officer Neutral 90.0 +16,419 16.84% ✗ -
Dec 12, 2025 Dec 16, 2025 Savchuk Nikolay COO Neutral 90.0 +16,419 12.24% ✗ -
Nov 21, 2025 Nov 25, 2025 Leaman John Harold Director Neutral 52.5 - 0.00% ✗ -
Oct 12, 2025 Oct 15, 2025 Savchuk Nikolay COO Neutral 52.5 - 0.00% ✗ -
Oct 12, 2025 Oct 15, 2025 Redfield Robert Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Oct 12, 2025 Oct 15, 2025 Pauza Charles David Chief Science Officer Virology Neutral 52.5 - 0.00% ✗ -
Oct 12, 2025 Oct 15, 2025 Dukes Iain D. CEO Neutral 52.5 - 0.00% ✗ -
Oct 12, 2025 Oct 15, 2025 CAUTREELS WERNER Director Neutral 52.5 - 0.00% ✗ -
Oct 12, 2025 Oct 15, 2025 STOVER JACK E Director Neutral 52.5 - 0.00% ✗ -
Oct 12, 2025 Oct 15, 2025 Clarke Trafford Director Neutral 52.5 - 0.00% ✗ -
Oct 12, 2025 Oct 15, 2025 Shoemaker Mary Teresa Director Neutral 52.5 - 0.00% ✗ -
Oct 1, 2025 Oct 14, 2025 Leaman John Harold Director Neutral 52.5 - 0.00% ✗ -
Oct 14, 2025 Leaman John Harold Director Neutral 52.5 - 0.00% ✗ -
Jun 19, 2025 Jun 23, 2025 Clarke Trafford Director Neutral 52.5 - 0.00% ✗ -
Jun 19, 2025 Jun 23, 2025 STOVER JACK E Director Neutral 52.5 - 0.00% ✗ -
Jun 19, 2025 Jun 23, 2025 Shoemaker Mary Teresa Director Neutral 52.5 - 0.00% ✗ -
Jun 19, 2025 Jun 23, 2025 CAUTREELS WERNER Director Neutral 52.5 - 0.00% ✗ -
Apr 2, 2025 Apr 8, 2025 TPAV, LLC 10% Owner Neutral 27.5 -605,531 -100.00% ✗ -
Feb 18, 2025 Feb 19, 2025 CAUTREELS WERNER CEO Neutral 52.5 - 0.00% ✗ -
Feb 10, 2025 Guerin Mark Patrick CFO Neutral 52.5 - 0.00% ✗ -
Feb 7, 2025 Brennan Nora CFO Neutral 52.5 - 0.00% ✗ -
Dec 29, 2024 Jan 27, 2025 ORBIMED ADVISORS LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Dec 29, 2024 Jan 27, 2025 CAUTREELS WERNER CEO Neutral 52.5 - 0.00% ✗ -
Dec 29, 2024 Jan 27, 2025 TPAV, LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Dec 29, 2024 Jan 27, 2025 Savchuk Nikolay COO Neutral 52.5 - 0.00% ✗ -
Sep 23, 2024 ORBIMED ADVISORS LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Sep 16, 2024 Sep 17, 2024 Greenwood Luba Director Neutral 52.5 - 0.00% ✗ -
Sep 17, 2024 Greenwood Luba Director Neutral 52.5 - 0.00% ✗ -
Apr 1, 2024 Aug 7, 2024 Dukes Iain D. Chair Neutral 90.0 +67,500 101.22% ✗ -
Apr 1, 2024 Aug 7, 2024 Savchuk Nikolay COO Neutral 90.0 +67,500 101.22% ✗ -
Jun 10, 2024 Jun 20, 2024 Guerin Mark Patrick CFO Sell 27.5 -2,221 -5.35% ✗ $1K
Apr 12, 2024 ORBIMED ADVISORS LLC Other Neutral 52.5 - 0.00% ✗ -
Apr 11, 2024 TPAV, LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Apr 1, 2024 Apr 3, 2024 Redfield Robert Acting Chief Medical Officer Neutral 90.0 +97,500 100.00% ✗ -
Apr 1, 2024 Apr 3, 2024 Pauza Charles David Chief Science Officer Virology Neutral 90.0 +97,500 100.00% ✗ -
Apr 1, 2024 Apr 3, 2024 CAUTREELS WERNER CEO Neutral 90.0 +200,000 100.00% ✗ -
Apr 1, 2024 Apr 3, 2024 Savchuk Nikolay COO Neutral 90.0 +2,664,869 3999.08% ✗ -
Apr 1, 2024 Apr 3, 2024 Dukes Iain D. Chair Neutral 90.0 +1,779,337 2670.19% ✗ -
Apr 3, 2024 Viriom, Inc. 10% Owner Neutral 52.5 - 0.00% ✗ -
Apr 3, 2024 ORBIMED ADVISORS LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Apr 3, 2024 Redfield Robert Acting Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Apr 3, 2024 Pauza Charles David Chief Science Officer Virology Neutral 52.5 - 0.00% ✗ -
Apr 3, 2024 CAUTREELS WERNER CEO Neutral 52.5 - 0.00% ✗ -
Apr 3, 2024 TPAV, LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Apr 3, 2024 Savchuk Nikolay COO Neutral 52.5 - 0.00% ✗ -
Apr 3, 2024 Dukes Iain D. Chair Neutral 52.5 - 0.00% ✗ -
Mar 13, 2024 Mar 15, 2024 Guerin Mark Patrick CFO Sell 27.5 -2,591 -6.72% ✗ $2.3K
Mar 13, 2024 Mar 15, 2024 Fruchtman Steven M CEO Sell 27.5 -8,727 -10.45% ✗ $7.9K
Feb 7, 2024 Feb 9, 2024 Guerin Mark Patrick CFO Sell 27.5 -2,443 -7.55% ✗ $1.6K
Feb 7, 2024 Feb 9, 2024 Fruchtman Steven M CEO Sell 27.5 -9,212 -13.23% ✗ $6.2K
Oct 2, 2023 Oct 27, 2023 Moyo Victor M CHIEF MEDICAL OFFICER Neutral 52.5 - 0.00% ✗ -
Oct 27, 2023 Moyo Victor M CHIEF MEDICAL OFFICER Neutral 52.5 - 0.00% ✗ -
Aug 10, 2023 Aug 14, 2023 Shoemaker Mary Teresa Director Neutral 52.5 - 0.00% ✗ -
Aug 10, 2023 Aug 14, 2023 STOVER JACK E Director Neutral 52.5 - 0.00% ✗ -
Aug 10, 2023 Aug 14, 2023 Atadja Peter Director Neutral 52.5 - 0.00% ✗ -
Aug 10, 2023 Aug 14, 2023 Clarke Trafford Director Neutral 52.5 - 0.00% ✗ -
Aug 10, 2023 Aug 14, 2023 MEHTA VIREN Director Neutral 52.5 - 0.00% ✗ -
Aug 10, 2023 Aug 14, 2023 GROOPMAN JEROME Director Neutral 52.5 - 0.00% ✗ -
Aug 10, 2023 Aug 14, 2023 MARINO JAMES J Director Neutral 52.5 - 0.00% ✗ -
Aug 2, 2023 Aug 4, 2023 Guerin Mark Patrick CFO Sell 27.5 -1,422 -5.29% ✗ $1.5K
Aug 2, 2023 Aug 4, 2023 Fruchtman Steven M CEO Sell 27.5 -4,744 -8.94% ✗ $4.8K
Jun 12, 2023 Jun 13, 2023 Guerin Mark Patrick CFO Sell 27.5 -1,575 -6.65% ✗ $1.8K
Mar 13, 2023 Mar 14, 2023 Guerin Mark Patrick CFO Neutral 52.5 - 0.00% ✗ -
Mar 13, 2023 Mar 14, 2023 Fruchtman Steven M CEO Neutral 52.5 - 0.00% ✗ -
Mar 13, 2023 Mar 14, 2023 Gelder Mark S. MD CHIEF MEDICAL OFFICER Neutral 52.5 - 0.00% ✗ -
Feb 7, 2023 Feb 8, 2023 Fruchtman Steven M CEO Sell 27.5 -6,977 -14.70% ✗ $9.5K
Feb 7, 2023 Feb 8, 2023 Gelder Mark S. MD CHIEF MEDICAL OFFICER Sell 27.5 -1,242 -10.59% ✗ $1.7K
Feb 7, 2023 Feb 8, 2023 Guerin Mark Patrick CFO Sell 27.5 -1,785 -8.94% ✗ $2.4K
Dec 15, 2022 Dec 19, 2022 Clarke Trafford Director Neutral 52.5 - 0.00% ✗ -
Dec 15, 2022 Dec 19, 2022 Atadja Peter Director Neutral 52.5 - 0.00% ✗ -
Dec 19, 2022 Clarke Trafford Director Neutral 52.5 - 0.00% ✗ -
Dec 19, 2022 Atadja Peter Director Neutral 52.5 - 0.00% ✗ -
Aug 18, 2022 Aug 19, 2022 STOVER JACK E Director Neutral 52.5 - 0.00% ✗ -
Aug 18, 2022 Aug 19, 2022 MARINO JAMES J Director Neutral 52.5 - 0.00% ✗ -
Aug 18, 2022 Aug 19, 2022 MEHTA VIREN Director Neutral 52.5 - 0.00% ✗ -
Aug 18, 2022 Aug 19, 2022 Shoemaker Mary Teresa Director Neutral 52.5 - 0.00% ✗ -
Aug 18, 2022 Aug 19, 2022 GROOPMAN JEROME Director Neutral 52.5 - 0.00% ✗ -
Aug 2, 2022 Aug 4, 2022 Guerin Mark Patrick CFO Sell 27.5 -1,355 -9.39% ✗ $1.8K
Aug 2, 2022 Aug 4, 2022 Gelder Mark S. MD CHIEF MEDICAL OFFICER Sell 27.5 -1,135 -16.14% ✗ $1.5K
Aug 2, 2022 Aug 4, 2022 Fruchtman Steven M CEO Sell 27.5 -4,562 -14.86% ✗ $6K
Jun 10, 2022 Jun 13, 2022 Guerin Mark Patrick CFO Neutral 52.5 - 0.00% ✗ -
Feb 7, 2022 Feb 9, 2022 Gelder Mark S. MD Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Feb 7, 2022 Feb 9, 2022 Fruchtman Steven M CEO Neutral 52.5 - 0.00% ✗ -
Feb 7, 2022 Feb 9, 2022 OLER ABRAHAM N. SVP Corp Dev & Gen Counsel Neutral 52.5 - 0.00% ✗ -
Feb 7, 2022 Feb 9, 2022 Guerin Mark Patrick CFO Neutral 52.5 - 0.00% ✗ -
Jan 28, 2022 Jan 31, 2022 OLER ABRAHAM N. SVP Corp Dev & Gen Counsel Buy 85.0 +1,500 6.52% ✓ $2.5K
Jan 21, 2022 Jan 24, 2022 OLER ABRAHAM N. SVP Corp Dev & Gen Counsel Buy 85.0 +1,500 6.97% ✓ $3K
Jan 14, 2022 Jan 18, 2022 OLER ABRAHAM N. SVP CORP DEV & GEN COUNSEL Buy 85.0 +1,500 7.49% ✓ $3.3K
Jan 7, 2022 Jan 10, 2022 OLER ABRAHAM N. SVP Corp Dev & Gen Counsel Buy 85.0 +1,500 8.10% ✓ $3.6K
Nov 19, 2021 Nov 23, 2021 OLER ABRAHAM N. SVP CORP DEV & GEN COUNSEL Buy 85.0 +1,000 5.71% ✗ $3.2K
Nov 18, 2021 Nov 19, 2021 OLER ABRAHAM N. SVP Corp Dev & Gen Counsel Neutral 52.5 - 0.00% ✗ -
Sep 28, 2021 Sep 29, 2021 OLER ABRAHAM N. SVP Corp Dev & Gen Counsel Buy 91.3 +2,381 23.50% ✗ $10K
Sep 28, 2021 Sep 29, 2021 Gelder Mark S. MD Chief Medical Officer Buy 91.3 +2,381 100.00% ✗ $10K